T he granting of clinical staff privileges to physicians is a primary mechanism used by institutions to uphold the quality of patient care. The Joint Commission on Accreditation of Healthcare Organizations requires that the granting of continuing medical staff privileges be based on assessments of applicants in accordance with professional criteria specified in the medical staff bylaws. Physicians and other healthcare providers are thus charged with identifying the criteria that constitute professional competence and with evaluating their peers accordingly. The process of evaluating clinical knowledge and competence is often constrained by the evaluator's knowledge and ability to elicit the appropriate information, a problem that is compounded by the growing number of highly specialized procedures for which privileges are requested.
The American College of Cardiology (ACC)/American Heart Association (AHA)/American College of PhysiciansAmerican Society of Internal Medicine (ACP-ASIM) Task Force on Clinical Competence was formed in 1998 to develop recommendations to attain and maintain the cognitive and technical skills necessary for the competency performance of a specific cardiovascular service, procedure, or technology. These documents are evidence based, and where evidence is not available, expert opinion is used to formulate recommendations. Indications and contraindications for specific services or procedures are not included in the scope of these guidelines. Recommendations are intended to assist those who must judge the competence of cardiovascular healthcare providers who are entering practice for the first time and those who are in practice and undergo periodic review of their practice expertise. Because the assessment of competence is complex and multidimensional, the isolated recommendations given here may not be sufficient or appropriate for the judgment of overall competence. Board specialty certification is not a required part of these guidelines but rather is another measure of expertise.
The ACC/AHA/ACP-ASIM Task Force on Clinical Competence makes every effort to avoid any actual or potential
Introduction
This statement is a revision and extension of the 1994 ACP/ACC/AHA document on clinical competence in invasive cardiac electrophysiological studies (EPSs) (1) and the 1993 report on elective direct current cardioversion (DCCV) (2) . This statement is designed to assist in the assessment of physicians' competence on a procedure-specific basis. The minimum education, training, experience, and cognitive and technical skills necessary for the competent performance of invasive cardiac EPSs, catheter ablation, and cardioversion are specified. It is important to note that these are minimum training and experience requirements for the assessment of competence in these disciplines (or procedures) in the broadest sense. Whenever possible, the specifications are based on published data that link these factors with competence or, in the absence of such data, on the consensus of expert opinion. The specifications are applicable to any practice setting and can accommodate a number of ways in which physicians can substantiate competence in the performance of specific procedures (3) . Expertise in the performance of these procedures in patients with infrequently encountered diagnoses or of less commonly performed variations of standard procedures may require additional experience or training. It is therefore expected that even highly competent practitioners will occasionally benefit from consultation with colleagues who have even more highly specialized interests, experience, or skills.
In addition to members of ACC, AHA, and ACP-ASIM, the Writing Committee was broadened to include a representative from the North American Society of Pacing and Electrophysiology (NASPE). Representation by an outside organization does not necessarily imply endorsement. In addition to content peer reviewers, "official" reviewers were provided by ACC, AHA, NASPE, and the American Board of Internal Medicine (ABIM). This document was approved for publication by the governing bodies of ACC and AHA. In addition, NASPE's governing board formally endorsed this document.
Clinical Competence in Invasive EPS, Catheter Ablation, and Cardioversion

Overview of the Procedure
Catheter techniques for the recording of the His bundle potential in humans were first reported in 1969 by Scherlag et al (4) . Initially, data from EPSs were used to determine the mechanisms of spontaneously occurring arrhythmias, including atrioventricular (AV) conduction abnormalities, premature complexes, and a variety of tachycardias (5, 6) . Subsequently, techniques for programmed electrical stimulation were developed, which permitted the reproducible initiation of both supraventricular (6,7) and ventricular (8 -10) arrhythmias in the laboratory. Pacing protocols to characterize sinus node function (11) and AV conduction (12) were also introduced. Because sustained arrhythmias are often episodic in nature or can terminate spontaneously or require intervention before full clinical evaluation, invasive EPSs have become a standard means of reproducing an arrhythmia in a controlled laboratory setting.
In this report, the term "EPS" refers to a procedure that involves the recording of intracardiac electrical signals and programmed electrical stimulation. The EPS either may be performed for diagnostic purposes only or may be part of a combined diagnostic and therapeutic (eg, ablation) procedure. Although a thorough description of EPSs is beyond the scope of this document, the procedure is briefly outlined here.
An EPS requires the placement of electrode catheters for pacing and recording in multiple cardiac chambers. The designs of the catheters and the sites appropriate for their placement are determined according to the nature of the arrhythmia under investigation. Typically, each catheter will have multiple electrode poles for both recording and local stimulation. Many types of specially designed catheters have been developed to facilitate recording and stimulation, and new catheters are frequently introduced into clinical practice. The intracardiac signals are acquired, amplified, filtered, displayed, stored, and analyzed, either in real time or for subsequent offline review. A potentially important part of an EPS is the use of intracardiac recordings to determine activation sequences during arrhythmias. This process is usually called "mapping." Analyses of the responses of an arrhythmia to various pacing techniques are also components of the mapping process.
EPSs provide clinically valuable diagnostic information. In patients with bradyarrhythmias, EPSs are occasionally necessary to clarify electrocardiographic phenomena or to explain symptoms that are possibly due to a transient, clinical bradyarrhythmia. EPSs are useful to determine the mechanisms and physiological characteristics and drug responses of supraventricular tachycardias and to determine whether arrhythmias are suitable for drug, device, or ablation therapy, as described later in this document. In patients with ventricular tachycardia, EPSs are useful to confirm the mechanism of the arrhythmia, to assess the effects of pharmacological therapy, and to select patients for nonpharmacological treatment. Acute or follow-up testing for antiarrhythmic device efficacy falls under the definition of "EPS." These studies can often be performed noninvasively through the device, but the placement of temporary catheters may be necessary.
EPSs have also been used to assess the future risk of serious antiarrhythmic events and to provide data on which prophylactic therapy may be based (13) . In patients with undocumented symptoms that suggest an arrhythmia that was not previously documented (eg, syncope or palpitations), EPSs are frequently used to assess the patient's predisposition for spontaneously occurring arrhythmias (14) .
Physicians involved in the performance of invasive EPSs should be cognizant of the indications, contraindications, and potential complications of the procedure in a given patient (14, 15) . Absolute contraindications to EPSs are few but include unstable ischemia, bacteremia or septicemia, acute decompensated congestive heart failure not caused by the arrhythmia, major bleeding diathesis, and lower extremity venous thrombosis, if femoral vein cannulization is desired. The appropriate use of invasive EPSs therefore requires a careful preprocedural assessment to ensure that the patient is stable and able to tolerate the procedure.
In the vast majority of situations, an EPS is performed on an elective basis. However, an EPS is justifiable in such situations if an arrhythmia is the main or major cause of the emergency, as occurs in patients with incessant ventricular or supraventricular tachycardia. General indications for invasive EPSs were recently described by the ACC/AHA Task Force on Practice Guidelines, in conjunction with NASPE (16).
Justification for Recommendation
The recommendations for minimum education, training, experience, and skills necessary to perform EPSs are based on a review of statements by ACP, ACC, and AHA (1, 17) ; the Canadian Cardiovascular Society (18) ; and the British Cardiac Society and Royal College of Physicians (19) ; a report from a Core Cardiology Training Symposium (COCATS) (20) ; and policies of the Accreditation Council of Graduate Medical Education (ACGME) (21) and ABIM (22) Tables 2 and 3 . Expertise in invasive EPSs requires the ability to safely and efficiently perform the catheterization procedures for intracardiac recording and stimulation. The operator must possess a thorough understanding of the basic electrophysiological mechanisms and clinical manifestations of arrhythmias, the applications and limitations of the available recording and stimulation technologies, the pharmacological effects of medications used during the studies, and the risks, benefits, and applications of nonpharmacological therapy. Because knowledge in all of these areas has increased, the interpretation and application of data acquired in the electrophysiological laboratory have become increasingly complex. The accurate interpretation of data is critical for optimal prescription of both pharmacological and nonpharmacological therapies.
Minimum Training Necessary for Competence
There is general agreement that a minimum of 1 year of specialized training in EPS is needed to acquire the cognitive and technical skills required to become expert in CCEP. This is in addition to time spent during general cardiology fellowship training learning to diagnose and manage arrhythmias. Training should take place in a laboratory that offers experi- ence with a diverse patient population who manifest a broad variety of arrhythmias. During the specialized training year, it is recommended that each trainee be a primary operator and analyze 100 to 150 initial diagnostic studies. At least 50 of these procedures should involve patients with supraventricular arrhythmias. Because therapy with antiarrhythmic devices forms a major part of current electrophysiology practice, the trainee should also have been a primary operator during Ն25 electrophysiological evaluations of implantable antiarrhythmic devices. The trainee's experience should be documented in writing and confirmed by the laboratory supervisor. For each procedure during the training period, the following facts should be documented: date, patient identification number, patient age, indication, type of procedure, findings, and complications. Respondents to the CCEP Training Program Directors' Survey uniformly indicated that 2 years were required to achieve training in all aspects (diagnostic and therapeutic) of CCEP.
Alternate Routes to Achieve Competence
In the absence of completion of the formal 1-year training program, competence in CCEP is difficult to achieve. The current requirement for residency education in CCEP as stated by the ACGME is 1 year of training in an ACGME electrophysiology program after the completion of an accredited cardiovascular disease residency program (21) . This requirement must be met to sit for the ABIM subspecialty examination in CCEP (22) . For those who choose to gain competency in the performance of EPSs but not within an accredited US program, training should still be completed in a structured environment. The operator should perform the same number of the above-listed procedures as currently recommended for US trainees. He or she should also participate in courses designed to provide specific instruction in CCEP. Prior competency statements have suggested a minimum of 30 hours of continuing medical education (CME) every 2 years; this recommendation is endorsed in the present document. Any such training should be performed under the supervision and mentorship of a recognized expert in the field of cardiac electrophysiology who has achieved board certification by the ABIM in CCEP or an equivalent degree of training in countries outside the United States. The trainee who completes this latter program in a training program that is not approved by the ACGME will not be eligible to take the ABIM examination.
Maintenance of Competence
As is true for many other procedures, a minimum number of cases are necessary to ensure continued proficiency in quality of care. The individual should participate in Ն100 diagnostic EPSs per year to maintain skills and should attend Ն30 hours of formal CME (level I category) every 2 years to remain abreast of changes in knowledge and in technology.
Catheter Ablation
Overview of the Procedure
Catheter ablation has revolutionized the field of electrophysiology. The performance of catheter ablation was initially accomplished through the delivery of high-energy, DC shocks (23, 24) . These early procedures had limitations in usefulness and safety because of barotrauma. They also carried the potential for significant complications, such as cardiac tamponade and the early or late occurrence of sudden death (25, 26) . Technological advancements in the late 1980s led to the ability to apply continuous-wave unmodulated radiofrequency energy through catheters to heat myocardium at the catheter-tissue interface, creating ablative lesions (27) . Although initial success rates were modest (27, 28) , further development in technology resulted in a technique that has replaced DC energy delivery (29, 30) . Radiofrequency ablation has also quickly supplanted open-heart surgery for several arrhythmias and is an acceptable alternative to longterm drug treatment. The lesions created by radiofrequency are well demarcated. This characteristic, along with improved catheter technology, allows very specific and focal energy delivery, which permits the cure of many arrhythmias. Through targeting of the specific site of origin of the arrhythmia, as with atrial tachycardia, or through interruption of a critical pathway needed for the maintenance of a reentrant arrhythmia, such as an accessory pathway, many arrhythmias of various mechanisms can be eliminated. Since its inception, catheter ablation has grown tremendously in its application. The number of reported ablation procedures performed annually in the United States has increased from 450 in 1989 to Ϸ15 000 annually (31) . The success rates reported in the 1995 Scheinman (31) survey of 157 laboratories in the United States were 97% for AV node ablations, 90% for accessory pathways in all locations, 94% for AV node modifications in the treatment of AV nodal reentry, 72% for the treatment of atrial flutter, and 71% for the treatment of atrial tachycardia. Complication rates derived from the Scheinman survey and the 1993 Multicentre European Radiofrequency Survey (MERFS) from 86 institutions (32) were reported in just under 4% of AV node interruptions, 2.6% of accessory pathway ablations, 1.7% of AV node modifications, and 1.6% of flutter and atrial tachycardia ablations.
Although the incidence of complications is low, serious complications can occur and include valvular disruption, coronary occlusion, cerebrovascular accident, and death. In US centers, procedural deaths occur in 0.2% of patients who undergo AV node ablation and 0.1% of patients with accessory pathways (31) . The most common complication in AV node modification has been the development of heart block through the inadvertent ablation of both the fast and slow AV nodal pathways. In the 1996 study from the MERFS (33), 4.7% of patients developed heart block during AV node modification. Heart block was significantly higher in patients in whom the fast pathway was targeted (5.3%) rather than the slow pathway (2%). This is higher than the overall rate of inadvertent heart block reported by Calkins et al (34) from the Atakr Multicenter Ablation Investigators Group, in which the incidence of inadvertent heart block in patients who underwent AV node modification was 1.3%. Importantly, a slow pathway ablation approach was used in this study. This study also reported serious complications in 3% of patients and minor complications in 8%.
Despite these complications, studies have clearly shown that symptomatic patients are afforded important improvements in the quality of life with catheter ablation (35) (36) (37) (38) . The benefit gained through arrhythmia treatment with catheter ablation is superior to that achieved through medical therapy. The cost of catheter ablation, although not trivial, is less over time than the cost of alternatives such as medical therapy or surgical interventions (35, 39) .
Catheter ablation provides a safe and highly effective treatment for symptomatic patients with supraventricular tachycardia. Ablation should not be reserved as a last resort treatment but is appropriate to consider, in some cases, as first-line therapy (eg, a symptomatic patient with WolffParkinson-White syndrome) (40 -45) . However, for patients with rhythm disturbances that are likely to spontaneously resolve (eg, atrial tachycardia) or unlikely to recur (eg, a first episode of atrial flutter), ablation would not be appropriate first-line therapy (46) . Its role would be limited to patients in whom medical therapy is intolerable or in whom there is evidence for adverse consequences of the arrhythmia. The complete list of indications is detailed in the ACC/AHA guidelines for CCEP and catheter ablation procedures (16) .
AV node reentry in a structurally normal heart typically is a benign arrhythmia, and there is a reasonable chance that no therapy is required (47) . However, if patients have other compounding heart disease, such as coronary artery disease, or if the arrhythmia produces hemodynamic compromise or intolerable side effects, ablation can be considered as firstline treatment because of the high likelihood of recurrence or of serious consequences to the arrhythmia (47) .
The role of ablation in the treatment of atrial fibrillation (AF) is still primarily restricted to AV node ablation and pacemaker implantation when medical therapy is not successful (37) . Direct curative ablation of the AF may be feasible for focal AF and shows some promising development but is not yet ready to be considered a primary treatment for AF (48) .
Radiofrequency ablation has been applied in the treatment of ventricular tachycardia in ischemic disease, bundle-branch reentry, and idiopathic tachycardia (49 -52) . A decision to perform an ablation in a patient with ventricular tachycardia must take into account the risks and benefits of doing so as well as subsequent risks of arrhythmia occurrence in abnormal but unablated tissue.
Justification for Recommendations
The performance of catheter ablation requires skills detailed previously as necessary for the performance of diagnostic electrophysiological testing. The indications, contraindications, and complications for catheter ablation are largely derived from the ACC/AHA guidelines for clinical intracardiac electrophysiological and catheter ablation procedures (16) . The performance of catheter ablation requires the ability and dexterity to successfully manipulate catheters in all locations of the heart to achieve adequate contact between the catheter and the myocardium to create curative lesions. This requires detailed knowledge of cardiac anatomy. Left-sided arrhythmia substrates such as left atrial foci usually require the ability to perform transseptal catheterization (53) . In some laboratories, this approach is routinely used for left-sided accessory pathways as well. For these pathways, a knowledge of transseptal and the retrograde aortic technique is needed (53, 54) . A thorough knowledge of arrhythmia mechanisms and the treatment of complex arrhythmias, including pharmacological effects, is a predicate to catheter ablation. The ability to interpret complex mapping with multiple intracardiac electrograms is required.
Because the possibility of creating AV heart block through the application of radiofrequency energy exists either as a desired end point or as an inadvertent result of energy application, physicians who perform ablations should be capable of managing the bradyarrhythmia and AV heart block.
Minimum Training Necessary for Competence
Program requirements for residency education in CCEP are outlined by the ACGME and effective as of July 1999 (21) . Training in an accredited program is required for admission to the ABIM examination for certification in CCEP. Programs accredited for training in CCEP must function as a part of an accredited subspecialty fellowship in cardiovascular disease. These programs should also meet the training in specialized electrophysiology, cardiac pacing, and arrhythmia management guidelines outlined by COCATS Task Force 6 (20) .
The performance of catheter ablation procedures requires skills that are developed over time. Several studies have shown that success rates improve and fluoroscopy times decrease with experience (55) (56) (57) (58) . Although there are many determinants of arrhythmia recurrences, recurrence rates drop with operator experience (59) . Each of these studies involved operators with extensive prior experience in electrophysiology, and it would be expected that the number of procedures required for a new trainee to gain expertise in ablation would
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be higher than that for an experienced electrophysiologist. The risks of ablation similarly have been reported by experienced operators. The MERFS volunteer registry reported an overall complication rate of 4.6% at high-volume centers (Ͼ100 ablations/year) compared with 5.6% at low-volume centers (Ͻ50 ablations/year) (32) . Similar data were reported in the 1994 NASPE survey, with a 1.5% complication rate at high-volume centers (Ͼ50 cases/year) and a 3.2% rate at low-volume centers (Ͻ20 ablations/year) (52). It is strongly recommended that all physicians who perform ablations in the United States meet the minimum ACGME training requirements for education in CCEP. Although credentialing at most institutions does not require board certification in CCEP, applicants should have met board requirements. The current program requirements for training in electrophysiology are for 12 months of specialty training after the completion of training in cardiovascular disease. This should provide adequate training for the performance of routine electrophysiological procedures. Training in electrophysiology and ablation techniques can occur simultaneously with incremental responsibility for the trainee during the entire period. However, most training program directors agree that to gain expertise in interventional electrophysiology and catheter ablation, additional training is required. Adequate training in all aspects of electrophysiology, including ablation, is expected to take 1 to 2 years after the completion of a 3-year training program in cardiovascular disease (18, 37, 39, 40, 60, 61) .
It is anticipated that the more experienced the electrophysiologist is, the quicker she or he will learn new techniques. As such, it is difficult to set requirements for a number of procedures to gain proficiency. The North American Society of Pacing and Electrophysiology Ad Hoc Committee on Catheter Ablation has recommended that a physician who performs catheter ablation procedures should have been the primary operator on Ն30 ablations (62); this should include 15 accessory pathway ablations. The Canadian Cardiovascular Society Committee (18) recommends a training experience that includes the performance of 50 transvenous catheter ablations. The ACGME recommends a minimum of 75 catheter ablative procedures, including a mix of AV nodal reentrant tachycardia, atrial flutter, AV junction ablation, and ventricular tachycardia (21) . For left-sided mapping procedures, the COCATS guidelines (20) recommend 15 cases with the retrograde aortic approach. For transseptal catheterization experience, Ն10 procedures are recommended. The COCATS guidelines also recommend participation in 50 catheter ablation procedures. It is the consensus of this task force that for new trainees, the physician should be involved in 75 ablation procedures. It is notable that for candidates who take the first cardiac electrophysiology examination given by the ABIM, the pass rates were significantly higher for those who performed a greater number of ablations compared with those who performed a lesser number of procedures (63) . The CCEP Training Program Directors' Survey indicated that a minimum of 90 (mean; 100 median) cases were required to acquire clinical competence in catheter ablation.
Alternate Routes to Achieve Competence
At this time, it is anticipated that physicians who perform ablations will have either received instruction during their training or been among those who developed the technique. In the rare instance of a board-eligible or -certified electrophysiologist who desires to learn the techniques required for ablation, mentoring by an electrophysiologist who is trained in ablation should be pursued. Documentation of satisfactory completion of such training should be kept in a log book. It is anticipated that depending on the level of skill, a minimum of 75 procedures will be required. In addition, such an individual should participate in courses designed to provide specific instruction in the cognitive and technical skills required for catheter ablation as listed earlier.
Maintenance of Competence
The field of interventional electrophysiology is evolving rapidly. Although it is anticipated that most physicians who perform ablations will have received instructions during their training, newer techniques will arise that require new skills or adaptations of old skills. The maintenance of skills needed to perform ablations successfully with acceptably low complication rates requires continued clinical activity. It is recommended that physicians who perform ablations maintain a volume of Ͼ20 to 50 ablations/year. The CCEP Training Program Directors' Survey respondents indicate that to maintain competency in catheter ablation, a mean of 38 (median 50) cases/year are required.
With the future development of new techniques, it is likely that some form of retraining will be required. Every 2 years, physicians who are involved in ablation therapy should attend CME activities (Ն30 hours of category 1 credits) that pertain to interventional electrophysiology. For novel treatments, some form of monitoring should be considered. The CCEP Training Program Directors' Survey results indicated that to maintain competency in the performance of diagnostic EPSs, a mean of 49 (median 50) cases/year was required and that a mean of 49 (median 50) could be in association with the performance of ablation procedures.
Use of Emerging Technology and New Techniques: Assessment of Clinical Competence in Invasive Cardiac Electrophysiological Procedures
During the past 10 years, the technology of cardiac electrophysiology has evolved rapidly. The rather straightforward electrophysiological procedures from the diagnostic era have given way to the multicatheter techniques and accompanying technologies that are necessary for interventional practice. The 8-to 16-channel analog recording systems are being replaced in routine procedures with 16-to 48-channel, computer-based digital recording platforms. Furthermore, 48-to 128-channel mapping capabilities are being developed and increasingly applied in cardiac ablation procedures. These systems not only simultaneously record and display activation from multiple regions of the heart but also format both activation and voltage information in 3-and 4-dimensional renderings.
Electroanatomic magnetic mapping capabilities, for example, are being applied to aid in the diagnosis and nonpharmacological treatment of arrhythmias (64, 65) . These systems involve the interaction of a sensing unit in the catheter tip positioned within a triangulating magnetic field to display temporal activation in a 3-dimensional pseudoanatomic context. Noncontact mapping probes are also being used to record actual and virtual electrograms from the endocardial surface of each heart chamber. With this technology, cardiac activation can be displayed in terms of 3-dimensional isochronal and full cardiac cycle isopotential maps (66, 67) . Several other systems that use active signaling between multiple exclusively intracardiac catheter electrodes or the body surface and catheter electrodes are being developed to provide a 3-dimensional framework for cardiac arrhythmias (68, 69) . In each case, these new technologies increase the amount and complexity of data generated during a mapping procedure.
Two-dimensional fluoroscopic imaging is also being supplemented with intracardiac echocardiography. This approach has capabilities of visualizing cardiac structures, endocardial surfaces, and the interaction between interventional catheters and targeted structures that are superior to those available with fluoroscopy (70 -72).
Although not yet established as requisite or "core" equipment for the electrophysiology laboratory, these and other emerging technologies have had, and will continue to have, a major impact on the practice of cardiac arrhythmia management. It is also anticipated that additional new technologies will be developed at ever faster rates in the future.
Competence in the Use of Emerging Technology
This evolution of new means of diagnosing and treating arrhythmias is accompanied by an ever-increasing challenge to the practicing electrophysiologist. Specifically, the use of additional techniques and technologies will require the acquisition of sufficient cognitive and technical expertise to ensure safe and effective application. Although cardiac electrophysiology trainees may encounter these approaches and systems during their fellowships, by default, the majority of clinical electrophysiologists will first be exposed to, and begin using, emerging techniques and technologies outside of their training experience. As such, the skills required to record, compile, synthesize, integrate, render, interpret, and apply the resulting data will be acquired through alternative educational pathways.
Specific Training Requirements
The training required for proficiency in the application of new technologies and techniques will depend on the technology and procedures under consideration. When emerging techniques and technology represent straightforward incremental progress, their use may rely on already resident cognitive and technical skills. For example, many new intracardiac mapping technologies involve the same venous and arterial access skills, arrhythmia induction protocols, catheter positioning and mapping techniques, electrogram pattern recognition, and arrhythmia mechanism deduction previously acquired though years of training and clinical practice. In these cases, training should be focused on the appropriate operation of the system and interpretation and application of data displays.
In other cases, however, application of the emerging techniques and technology will undoubtedly represent a major paradigm shift in interventional approaches, thus requiring the accumulation of very different technical and cognitive skills than those required to use the current procedures or technology. In such cases, sufficient education and experience are imperative for both understanding the general operational principles behind that technology and ensuring sufficient technical abilities for the safe and efficient application of the technology. This exposure may come from national and local CME seminars; emerging scientific information from reputable, established scientific journals; local or regional training sessions; or on-site teaching by certified industry engineers. In any event, sufficient experience should be acquired such that the actual application of the technology and performance of the procedure are conducted safely under the direction of the practicing physician, without relegation of this responsibility to an industry representative. This obviously requires that a practitioner have a sufficient understanding of appropriate indications, contraindications, and risks for the application of that technology.
The duration of training or number of procedures required to establish competence will be dependent on the new techniques or technology used. This should be based on definable measures of individual competence and should include appropriate documentation of the specific cases undertaken, arrhythmias under study, general techniques and approaches used, and outcomes of the technology-related procedures. It is fully anticipated that some new technologies and techniques will lead to sufficiently specialized and frequent applications so as to require subsequent, independent competency guidelines. This has been the case in both pacemaker and defibrillator implantation and in cardiac ablation, as discussed in the preceding guidelines.
Finally, because of the additional complexity of interventions enabled through emerging technology, cardiac electrophysiology trainees may require additional time to acquire the fundamental proficiency necessary for an interventional practice. In any event, it remains increasingly critical that the practicing physician acquire and maintain an understanding of relevant first principles of electrophysiology. Although it is exciting, it should be kept in mind that the technology facilitates the application of those fundamental principles of electrophysiology only for the benefit of arrhythmia patients.
Clinical Competence in Elective DCCV
Overview of the Procedure
Since the introduction of DC transthoracic electrical shock (73) , its use has become fairly routine for the termination of tachycardias. A variety of clinical scenarios are now encountered in which transthoracic and, more recently, intracardiac DC electrical shock of variable energies is delivered (24,26,51,74 -76) . In urgent settings such as hemodynamic collapse associated with ventricular tachycardia or ventricular fibrillation, high-energy shock (ie, Ն200 J) is used. However, lower energies are used for elective cardioversion in more hemodynamically stable patients. Due to the potential risks involved, it is imperative that physicians be familiar with proper indications, precautions, techniques, and complications (77) . Elective DCCV that requires sedation or general anesthesia is the subject of this report. At the present time, DCCV can be carried out externally with chest electrodes (transthoracic) or endocardially with the use of electrode catheters (or leads). The 2 procedures are discussed separately where appropriate. (2) is carried out in a fasting, postabsorptive state with the patient under sedation or general anesthesia. A baseline 12-lead electrocardiogram is recorded, and venous cannulation is secured. The rhythm is displayed on the screen with a stable baseline. The electrodes (paddles) are placed in the anteroposterior or base-apex location. For atrial defibrillation, a more superoanterior left paddle position is often more effective. A clearly visible artifact that indicates the timing of the shock in relation to QRS is identified. DC shock is synchronized to the peak of the QRS. Under no circumstances should the shock be delivered on the T wave. Although the selection of a specific R wave may not be critical for high-energy depolarizing shock, it is desirable at low energies. Recent data suggest that a perfectly synchronized shock (to R wave) may still fall within the T wave of the previous R wave after an R-R interval of Ͻ300 ms (78) . Ideally, therefore, low-energy shocks should be synchronized to an R wave preceded by a long R-R interval. This feature, however, may not yet be available in commercially available external cardioverters. Physicians in charge should be thoroughly familiar with the device that is used for elective DCCV.
A. External Cardioversion
Once a satisfactory synchronization is obtained, sedation or anesthesia is initiated, and a shock is delivered (79, 80) . The initial shock energy may be as low as 50 J depending on the type of arrhythmia. After shock delivery, the rhythm is noted, and if conversion is unsuccessful, repeat DCCV is attempted with higher energy. This can be repeated until the arrhythmia terminates or a decision is made to abandon DCCV.
Before elective DCCV is performed, several precautions are worth noting:
1. Anticoagulation (81) (82) (83) . The most common arrhythmia subjected to elective DCCV is AF. Individuals with AF of Ͼ48 hours' duration should receive warfarin therapy for Ն3 weeks before and 4 weeks after the procedure. An INR goal of 2.5 (range 2.0 to 3.0) is recommended for most patients. For high-risk patients such as those with mechanical heart valves, an INR goal of 3 (range 2.5 to 3.5) is recommended. The routine use of warfarin therapy in arrhythmias other than AF is still controversial. 2. Although elective DCCV is effective in terminating a variety of tachycardias, it has no role in the prevention of subsequent episodes. In individuals with recurrent episodes, it is desirable that some form of therapy be planned for the prevention of the arrhythmia episodes. For this purpose, class I and class III agents are usually preferred and may be continued for a period of time after DCCV (84) . The concomitant use of AV nodal blocking agents is frequent but may not be necessary with the class III agents such as sotalol and amiodarone. 3. The use of transesophageal echocardiography has been advocated to identify small atrial thrombi that are not visible on transthoracic echocardiography. In patients in whom earlier cardioversion is desired, anticoagulation with heparin can be initiated and transesophageal echocardiography can be performed. If no clots are seen, cardioversion can be undertaken. Routine anticoagulation must still be maintained after cardioversion (85). 4. Several untoward and potentially life-threatening events may occur after DCCV shock: these include 1) the induction of ventricular tachycardia/fibrillation, 2) asystole, and 3) transient depression of myocardial function, particularly with repeated shocks and higher energies. Techniques to deal with these situations should be readily available to prevent potential complications.
The use of an intravenous antiarrhythmic such as ibutilide may result in the restoration of sinus rhythm, but if not, it may facilitate DCCV in patients for whom conventional cardioversion was unsuccessful (86, 87) .
B. Internal Cardioversion
In a significant number of patients for whom external DCCV was unsuccessful, an internal shock with the use of electrode catheters has been successful. (88, 89) The primary indication for internal DCCV is AF when external shock fails (74, 88, 89) . Evolution of this technology has facilitated the The safe delivery of DC shock and the limit of energy that can be delivered via electrode catheters
The use of conscious sedation or, when appropriate, anesthesia
The use of intravenous antiarrhythmic medications
Cognitive skills necessary for external DCCV (see Table 6 ) (76) . An additional reason is to assess the feasibility of an implantable atrial defibrillator (75) .
Internal cardioversion is performed with the patient under conscious sedation or general anesthesia (79, 80) . Specially designed electrode catheters with large surface areas are introduced percutaneously and placed in the right atrium and coronary sinus. The large surface area is achieved with either a coil or the connection of several electrodes to a common terminal (75) . A standard bipolar catheter is placed in the right ventricle for precise timing of ventricular activation and shock delivery. The 2 atrial catheters are used for DCCV (ie, between the coronary sinus and right atrium).
Depending on the defibrillating device that is used, synchronization to a particular R wave can be accomplished. Up to 10 J of energy can be safely delivered with the right atrium-coronary sinus vector, whereas 200 J has been safely delivered via an intracardiac-thoracic patch combination. It is important that the electrode catheters are kept away from the region of the AV node-His bundle when internal DCCV is performed. The postshock is analyzed, and the need for further DCCV at a similar or higher energy is evaluated. When symptomatic bradycardias are noted, they can be treated with atrial or ventricular pacing, or both.
Because of the potential risk of bleeding, warfarin therapy is usually withheld and resumed after the procedure. Temporary anticoagulation before and after the procedure can be accomplished with heparin. Preprocedural and postprocedural antiarrhythmic therapy considerations are similar to those for external DCCV. The possible risks of both right heart catheterization with electrode catheters and the fact that the DC shock is delivered within the myocardial structures add to specific complications. The settings in which these procedures are carried out must be equipped to handle all potential untoward sequelae.
Justification for Recommendation
The use of external as well as intracardiac DCCV is associated with a variety of serious risks to the patient. It is therefore important that the physicians have the cognitive skills and the technical know-how to safely conduct these therapies. Tables 4 to 7 summarize the requirements that will be considered essential to acquire.
The transthoracic procedure is widely used for the termination of tachycardias in both chronic and emergent settings. There is a broad-based pool of knowledge available regarding the clinical settings in which DCCV is used, including indications, contraindications, complications, and technologies that are used. However, there is no formal mechanism to determine the expertise of an individual who is qualified to perform DCCV. In previous publications regarding external DCCV, ACP, ACC, and the AHA Task Force collected data from accredited cardiology training programs and made the recommendations.
For internal DCCV, a separate level of knowledge and skill is required because of the invasive nature. Tables 4 and 5 outline the cognitive and technical skills needed to perform effective and safe DCCV.
Minimum Training Necessary for Competence
For external DCCV, the minimum training should include 1) competence in the interpretation of 12-lead electrocardiograms and 2) cognitive knowledge and skills, outlined in Tables 6 and 7 . It is imperative that the technical skills required to perform cardioversion are applied by those with an overall understanding of the procedure. Improperly performed DCCV can be both ineffective and harmful. Previous task force recommendations of a minimum of 8 supervised DCCVs seems appropriate as a minimum requirement. Although typical training in cardiovascular disease during a 3-year period may provide such an experience, it should be documented by the trainee and certified by appropriately trained supervisors. If formal training in cardiovascular disease does not provide adequate exposure to a sufficient number of DCCVs, competence in DCCV is not achieved. Conversely, the competence in DCCV may be achievable without formal training in cardiovascular disease.
For competency in internal DCCV, all of the abovementioned requirements for external DCCV must be met. It is inconceivable that someone could meet the competency criteria for internal DCCV without prior established minimum training needed for external DCCV. In addition, however, the candidate must meet the minimum competency requirement for the following: 
Maintenance of Competence
A minimum of 4 external DCCV procedures annually should be necessary to maintain initial certification. It is also important that a new body of knowledge be acquired as additional reliable data become available. Varying and changing technology also necessitates that the operator be familiar with the proper use of external DCCV equipment used in his or her clinical settings. The maintenance of competence in intracardiac DCCV requires a minimum of 2 annual procedures. In addition, necessary knowledge of upkeep and equipment changes must be maintained. This, of course, is done with the understanding that competency for diagnostic EPS is monitored concurrently. Individuals with experience in internal DCCV within the institution should look at the issue from the quality control perspective on a periodic basis. An outside consultant may be necessary if institutional expertise is not available.
